RYR1 expression was significantly reduced in hyperplastic and thymoma thymuses from corticosteroid-naïve, but not corticosteroid-treated, MG patients compared to control thymuses and non-MG thymomas, respectively (Figure 2a–c). This evidence concerns the gene RYR1 and myasthenia gravis.